Maternal group B streptococcal immunization: Capsular polysaccharide (CPS)-based vaccines and their implications on prevention

Vaccine

Volumn 29, Issue 21, 2011, Pages 3729-3730

  Palmeiro, Jussara K ^a,b   De Carvalho, Newton S ^a   Botelho, Ana C N ^c   Fracalanzza, Sérgio E L ^b   Madeira, Humberto M F ^a,d   Dalla Costa, Libera M ^a,b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

Author keywords

CPS based vaccine; Group B streptococcus; Serotype IV

Indexed keywords

BACTERIAL VACCINE; POLYSACCHARIDE VACCINE;

ADULT DISEASE; BACTERIAL MEMBRANE; DRUG EFFICACY; EUROPE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; IMMUNIZATION; LETTER; MOTHER; NEWBORN DISEASE; NONHUMAN; NORTH AMERICA; PREGNANCY DISORDER; PRIORITY JOURNAL; SEROTYPE;

FEMALE; HUMANS; IMMUNIZATION; POLYSACCHARIDES, BACTERIAL; PREGNANCY; PREVALENCE; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS AGALACTIAE; VACCINES, CONJUGATE;

EID: 79955099235     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.102     Document Type: Letter

References (18)

1. Phares C.R., Lynfield R., Farley M.M., Mohle-Boetani J., Harrison L.H., Petit S., et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299(17):2056-2065.
2. Slotved H.C., Kong F., Lambertsen L., Sauer S., Gilbert G.L., Serotype I.X. A proposed new Streptococcus agalactiae serotype. J Clin Microbiol 2007, 45(9):2929-2936.
3. Paoletti L.C., Wessels M.R., Rodewald A.K., Shroff A.A., Jennings H.J., Kasper D.L. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994, 62(8):3236-3243.
4. Baker C.J., Paoletti L.C., Wessels M.R., Guttormsen H.K., Rench M.A., Hickman M.E., et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999, 179(1):142-150.
5. Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., et al. Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006, 4(12):932-942.
6. Persson E., Berg S., Trollfors B., Larsson P., Ek E., Backhaus E., et al. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect 2004, 10(9):791-796.
7. Lachenauer C.S., Kasper D.L., Shimada J., Ichiman Y., Ohtsuka H., Kaku M., et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999, 179(4):1030-1033.
8. Paoletti L.C., Kasper D.L. Conjugate vaccines against group B streptococcus types IV and VII. J Infect Dis 2002, 186(1):123-126.
9. Palmeiro J.K., Dalla-Costa L.M., Fracalanzza S.E., Botelho A.C., da Silva Nogueira K., Scheffer M.C., et al. Phenotypic and genotypic characterization of group B streptococcal isolates in Southern Brazil. J Clin Microbiol 2010, 48(12):4397-4403.
10. Lancefield R.C., Freimer E.H. Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond) 1966, 64(2):191-203.
11. Amin A., Abdulrazzaq Y.M., Uduman S. Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 2002, 45(1):42-46.
12. Ekin I.H., Gurturk K. Characterization of bovine and human group B streptococci isolated in Turkey. J Med Microbiol 2006, 55(5):517-521.
13. Moyo S.R., Maeland J.A., Bergh K. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. J Med Microbiol 2002 Jul, 51(7):595-600.
14. Diedrick M.J., Flores A.E., Hillier S.L., Creti R., Ferrieri P. Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol 2010, 48(9):3100-3104.
15. Duarte R.S., Bellei B.C., Miranda O.P., Brito M.A., Teixeira L.M. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother 2005, 49(1):97-103.
16. Simoes J.A., Alves V.M., Fracalanzza S.E., de Camargo R.P., Mathias L., Milanez H.M., et al. Phenotypical characteristics of group B streptococcus in parturients. Braz J Infect Dis 2007, 11(2):261-266.
17. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999, 5(3):336-345.
18. Cieslewicz M.J., Chaffin D., Glusman G., Kasper D., Madan A., Rodrigues S., et al. Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun 2005, 73(5):3096-3103.